ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $115 | -34.3% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $175 | +9.4% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $160 | – | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |